We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Agrees to Pay $325 Million to Settle Neurontin Off-Labeling Suit
Pfizer Agrees to Pay $325 Million to Settle Neurontin Off-Labeling Suit
Pfizer has agreed to pay $325 million to private insurers to settle a decade-old lawsuit alleging the drug giant illegally marketed the epilepsy drug Neurontin for off-label purposes.